These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46 related articles for article (PubMed ID: 3223296)
1. Studies of the thyrotropic function of the adenopituitary of the offspring of rats treated during pregnancy with dopaminergic agents. Boyadjieva M; Zaharieva B; Ovtcharov R Acta Physiol Pharmacol Bulg; 1988; 14(3):63-6. PubMed ID: 3223296 [TBL] [Abstract][Full Text] [Related]
2. Effect of some benzodiazepines on the secretion of thyrotropic hormone and prolactin under conditions of experimental stress. Boyadjieva N; Ovtcharov R Acta Physiol Pharmacol Bulg; 1987; 13(2):18-21. PubMed ID: 2890258 [TBL] [Abstract][Full Text] [Related]
3. [Effect of dopaminergic pharmacological agents on thyrotropic hormone secretion by the hypophysis when stimulated with thyrotropin-releasing hormone]. Boiadzhieva N; Zakharieva B; Ovcharov R Eksp Med Morfol; 1985; 24(1):29-32. PubMed ID: 3928331 [No Abstract] [Full Text] [Related]
4. Influence of dopamine energic pharmacology drugs on secretion of the adrenocorticotropic hormone from the hypophysis. Milkov V; Pironcheva G; Miteva K; Russev G; Zlatarev S Microbios; 2000; 102(403):155-8. PubMed ID: 10955829 [TBL] [Abstract][Full Text] [Related]
5. [Validity of radioimmunoassay for blood and pituitary prolactin in the male rat. Effect of bromocriptine and thyrotropin-releasing hormone]. André M; Grizard G; Boucher D C R Seances Soc Biol Fil; 1981; 175(6):792-800. PubMed ID: 6459824 [TBL] [Abstract][Full Text] [Related]
6. Pre- and postnatal development studies of lasofoxifene, a selective estrogen receptor modulator (SERM), in Sprague-Dawley rats. Weisenburger WP; Hagler AR; Tassinari MS Birth Defects Res B Dev Reprod Toxicol; 2004 Jun; 71(3):171-84. PubMed ID: 15282738 [TBL] [Abstract][Full Text] [Related]
7. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat. Henry B; Crossman AR; Brotchie JM Exp Neurol; 1999 Feb; 155(2):204-20. PubMed ID: 10072296 [TBL] [Abstract][Full Text] [Related]
8. Effect of various neuroactive drugs on bromocriptine concentration in the striatum of rats. Vardi J; Graff E; Oberman Z; Flechter S; Rabey JM Isr J Med Sci; 1984 May; 20(5):407-9. PubMed ID: 6469560 [TBL] [Abstract][Full Text] [Related]
9. [Role of dopamine in the regulation of the thyrotropic function of the pituitary gland]. Babichev VN; Sidneva LN; Samsonova VM Probl Endokrinol (Mosk); 1978; 24(1):88-91. PubMed ID: 634953 [TBL] [Abstract][Full Text] [Related]
10. Dopaminergic control of adenohypophyseal growth after oestrogens: negative results with L-DOPA, RO-4-4602, alpha-methyl-DOPA, apomorphine, haloperidol, pyridoxine and cyproheptadine. Schreiber V; Pribyl T; Jahodová J Physiol Bohemoslov; 1978; 27(4):308-12. PubMed ID: 151287 [TBL] [Abstract][Full Text] [Related]
11. Age-related changes in rat brain dopaminergic receptors. Petkov VV; Petkov VD; Grahovska T; Konstantinova E Acta Physiol Pharmacol Bulg; 1984; 10(4):16-27. PubMed ID: 6535368 [TBL] [Abstract][Full Text] [Related]
13. De novo administration of ropinirole and bromocriptine induces less dyskinesia than L-dopa in the MPTP-treated marmoset. Pearce RK; Banerji T; Jenner P; Marsden CD Mov Disord; 1998 Mar; 13(2):234-41. PubMed ID: 9539335 [TBL] [Abstract][Full Text] [Related]
14. Prolactin inhibition at the end of lactation programs for a central hypothyroidism in adult rat. Bonomo IT; Lisboa PC; Passos MC; Alves SB; Reis AM; de Moura EG J Endocrinol; 2008 Aug; 198(2):331-7. PubMed ID: 18490438 [TBL] [Abstract][Full Text] [Related]
15. Interaction of antidepressants with antiparkinsonian agents in rats. Zebrowska-Lupina I; Porowska A; Pietrasiewicz T Pol J Pharmacol Pharm; 1985; 37(6):865-74. PubMed ID: 3832020 [TBL] [Abstract][Full Text] [Related]
16. Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease. Schneider MB; Murrin LC; Pfeiffer RF; Deupree JD Clin Neuropharmacol; 1984; 7(3):247-57. PubMed ID: 6435870 [TBL] [Abstract][Full Text] [Related]
17. Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease. Henry B; Crossman AR; Brotchie JM Exp Neurol; 1998 Jun; 151(2):334-42. PubMed ID: 9628768 [TBL] [Abstract][Full Text] [Related]
18. [Comparative action of L-dopa and bromocriptine on thyreostimulating hormone (T.S.H.) in primary hypothyroïdism (author's transl)]. Lefebvre J; Loeuille GA; Steinling M; Linquette M Nouv Presse Med; 1979 Oct; 8(38):3033-6. PubMed ID: 534166 [TBL] [Abstract][Full Text] [Related]
19. Neuro-endocrine effects of isotheoline. Zhelyazkov D; Markov M; Maleeva A; Visheva N; Milkov V Acta Physiol Pharmacol Bulg; 1984; 10(4):53-8. PubMed ID: 6535370 [TBL] [Abstract][Full Text] [Related]
20. Changes in the regulation of calcium metabolism and bone calcium content during growth in the absence of endogenous prolactin and during hyperprolactinemia: a longitudinal study in male and female Wistar rats. Piyabhan P; Krishnamra N; Limlomwongse L Can J Physiol Pharmacol; 2000 Oct; 78(10):757-65. PubMed ID: 11077975 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]